Showing results (101-110 of 191) with videos related to

Sort By:
Pageof 20
Cancer|February 28, 2009
Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant gliomaDavid A Reardon, Merrill J Egorin, Annick Desjardins, et al.
Cancer Chemotherapy and Pharmacology|October 31, 2012
In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenograftsJianxia Guo, Dana M Clausen, Jan H Beumer, et al.
Cancer Chemotherapy and Pharmacology|February 22, 2023
Evaluating the indotecan-neutropenia relationship in patients with solid tumors by population pharmacokinetic modeling and sigmoidal Emax regressionsJan H Beumer, Benjamin C Kennard, Julianne L Holleran, et al.
Cancer Chemotherapy and Pharmacology|September 19, 2020
Evaluation of the pharmacokinetic drug-drug interaction potential of iohexol, a renal filtration markerAnand Joshi, Jianxia Guo, Julianne L Holleran, et al.
Cancer Chemotherapy and Pharmacology|November 21, 2018
Population pharmacokinetics and exposure-response assessment of veliparib co-administered with temozolomide in patients with myeloid leukemiasRenu Singh, Shailly Mehrotra, Mathangi Gopalakrishnan, et al.
Clinical Pharmacology and Therapeutics|June 21, 2018
Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5-Fluorouracil TherapyJan H Beumer, Edward Chu, Carmen Allegra, et al.
JCI Insight|February 22, 2023
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapyFrank P Vendetti, Pinakin Pandya, David A Clump, et al.
Cancer Chemotherapy and Pharmacology|September 16, 2019
Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trialThehang Luu, Paul Frankel, Jan H Beumer, et al.
Cancer Chemotherapy and Pharmacology|September 17, 2013
Calcium carbonate does not affect nilotinib pharmacokinetics in healthy volunteersHussein A Tawbi, An L Tran, Susan M Christner, et al.
Molecular Cancer Therapeutics|August 24, 2022
Modular Smart Molecules for PSMA-Targeted ChemotherapyFeyisola P Olatunji, Michael Pun, Jacob W Herman, et al.
Pageof 20